aminolevulinic acid has been researched along with Lupus Erythematosus, Systemic in 2 studies
Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.
Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.
Excerpt | Relevance | Reference |
---|---|---|
"We describe a 38-year-old woman with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) who developed two symmetric paramalleolar ulcers with similar diameters, depths and borders, that were successfully treated with photodynamic therapy with 5-aminolevulinic acid (ALA-PDT)." | 3.74 | Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report. ( Monti, M; Motta, S, 2007) |
" We reported this case and the successful treatment of photodynamic therapy combined with surgical management." | 1.56 | Photodynamic therapy combined with surgical management of extensive anogenital condylomatosis in a patient with systemic lupus erythematosus. ( Dai, SQ; Huang, XW; Jiang, LF; Li, JP; Li, L; Wang, ML; Zeng, K, 2020) |
"We describe a 38-year-old woman with systemic lupus erythematosus (SLE) and antiphospholipid syndrome (APS) who developed two symmetric paramalleolar ulcers with similar diameters, depths and borders, that were successfully treated with photodynamic therapy with 5-aminolevulinic acid (ALA-PDT)." | 1.34 | Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report. ( Monti, M; Motta, S, 2007) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Huang, XW | 1 |
Jiang, LF | 1 |
Wang, ML | 1 |
Dai, SQ | 1 |
Li, JP | 1 |
Zeng, K | 1 |
Li, L | 1 |
Motta, S | 1 |
Monti, M | 1 |
2 other studies available for aminolevulinic acid and Lupus Erythematosus, Systemic
Article | Year |
---|---|
Photodynamic therapy combined with surgical management of extensive anogenital condylomatosis in a patient with systemic lupus erythematosus.
Topics: Aminolevulinic Acid; Condylomata Acuminata; Humans; Lupus Erythematosus, Systemic; Photochemotherapy | 2020 |
Photodynamic therapy-a promising treatment option for autoimmune skin ulcers: a case report.
Topics: Adult; Aminolevulinic Acid; Antiphospholipid Syndrome; Autoimmune Diseases; Female; Humans; Lupus Er | 2007 |